Dr.Finance (WAR:DRF) Total Stockholders Equity: zł0.07 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:DRF Dr.Finance SA WAR:DRF
43 GF Score
Price zł1.34
GF Value zł0.61
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Dr.Finance Total Stockholders Equity?

Dr.Finance WAR:DRF +3.47% 43 Total Stockholders Equity is zł0.07 Mil as of Mar. 2026. GuruFocus rates WAR:DRF with a GF Score™ of 43/100 and a GF Value™ of zł0.61 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Dr.Finance's Total Stockholders Equity for the quarter that ended in Mar. 2026 was zł0.07 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Dr.Finance's Book Value per Share for the quarter that ended in Mar. 2026 was zł0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Dr.Finance's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.00.


Dr.Finance  (WAR:DRF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Dr.Finance's Book Value per Share for the quarter that ended in Mar. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Dr.Finance's Debt-to-Equity for the quarter that ended in Mar. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr.Finance Total Stockholders Equity Related Terms


Dr.Finance Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Dr.Finance's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr.Finance Total Stockholders Equity Chart

Dr.Finance Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 0.58 0.56 0.31 0.11

Dr.Finance Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.32 0.24 0.11 0.07
WAR:DRF
43GF Score
Dr.Finance SA WAR:DRF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of zł0.07 Mil mean?
Dr.Finance (WAR:DRF) has a Total Stockholders Equity of zł0.07 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Dr.Finance and its competitors.
Is Dr.Finance's Total Stockholders Equity too high?
Dr.Finance's current Total Stockholders Equity is zł0.07 Mil. Overall, Dr.Finance has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr.Finance's Total Stockholders Equity compare to V and MA?
Dr.Finance's Total Stockholders Equity of zł0.07 Mil can be compared against companies in the Credit Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Credit Services company?
A good Total Stockholders Equity depends on the Credit Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Dr.Finance and its competitors. Dr.Finance's current Total Stockholders Equity is zł0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr.Finance stock overvalued right now?
Based on GuruFocus' analysis, Dr.Finance (WAR:DRF) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.61, compared to a current price of zł1.34 — trading 119.7% above its estimated fair value. The current Total Stockholders Equity is zł0.07 Mil. Dr.Finance's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Dr.Finance (WAR:DRF), the current Total Stockholders Equity is zł0.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr.Finance (WAR:DRF) Overvalued in 2026?

Based on GuruFocus' analysis, Dr.Finance stock appears to be overvalued. The current stock price of zł1.34 is trading 119.7% above its estimated GF Value™ of zł0.61. GuruFocus considers Dr.Finance to be Significantly Overvalued.

Key valuation signals for WAR:DRF:

  • Total Stockholders Equity: zł0.07 Mil
  • GF Value™: zł0.61 vs. price of zł1.34 (119.7% above fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the WAR:DRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr.Finance Business Description

Address ul. Braniborska 65/12, Wroclaw, POL, 53-680
Dr.Finance SA is a financial intermediary in the sale of loans and other financial products. It operates in the business of Working capital loans, Investment loans, Leasing, and Factoring.
43GF Score

Get the complete analysis for WAR:DRF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł1.34
Price
zł0.61
GF Value